Healthcare >> CEO Interviews >> April 14, 2002
DAVID A. DODD joined Serologicals Corporation as President, Chief
Executive Officer and Director in June 2000. From august 1995
until June 2000, he served as President and Chief Executive
Officer of Solvay Pharmaceuticals, Inc., and as a member of the
Management Board for the Pharmaceutical Sector for Solvay S.A.
Mr. Dodd also served as Chairman of the Board of Unimed
Pharmaceuticals, Inc., a subsidiary of Solvay Pharmaceuticals.
Prior to joining Solvay, he served in a number of management and
executive positions with major life science corporations,
including American Home Products, Bristol-Myers Squibb, and
Abbott Laboratories. Mr. Dodd currently serves on the Board of
Directors of the American Foundation for Suicide Prevention and
the Georgia Biomedical Partnership, as Chairman, and, is on the
Board of Advisors to the National Association of Corporate
Directors, Atlanta Chapter. He holds Bachelor of Science and
Master of Science degrees from Georgia State University and
completed the Harvard Business School Advanced Management
Program. Profile
Corporation and an overview of what you are doing at the present time?
Mr. Dodd: Serologicals Corporation was founded in
